News & Announcements

The FDA and the FNIH are co-hosting a public workshop on April 14 and 15 to discuss a framework for determining the levels of evidence required to qualify biomarkers for use in drug development.

Check out this Forbes article referencing the Eliminate Dengue Program for its efforts in using a bacteria-based biocontrol method to potentially stop the Zika and Dengue viruses.

The FNIH President and Executive Director, Dr. Maria Freire, speaks about the transformative nature of biomedical research.

Spotlight

Accelerating Medicines Partnership logo

In recognition of the 10th Anniversary of the Edmond J. Safra Family Lodge, the FNIH hosted an event honoring Mrs. Lily Safra of the Edmond J. Safra Philanthropic Foundation on the NIH campus.

Grand Challenges in Global Health

Launched by the Gates Foundation in 2003 as a collaboration with the FNIH, this was a major initiative focused on achieving scientific breakthroughs against diseases that kill millions of people each year in the world’s poorest countries.

Charles A. Sanders Legacy Fund

The Charles A. Sanders Legacy Fund was established by the FNIH as an impactful way to honor Dr. Sanders for his decades of tireless dedication to improving health, access to medical care and furthering biomedical research around the world.

Front Page: